Quick Answer
Stereotaxis, Inc. reported R&D Expense of $9.38 million for fiscal year 2025.
Stereotaxis, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.38M | -3.9% |
| 2024 | $9.76M | -5.0% |
| 2023 | $10.27M | -2.7% |
| 2022 | $10.56M | +3.5% |
| 2021 | $10.20M | +25.3% |
| 2020 | $8.14M | -9.8% |
| 2019 | $9.02M | +9.8% |
| 2018 | $8.22M | +22.6% |
| 2017 | $6.70M | +22.2% |
| 2016 | $5.49M | -12.2% |
| 2015 | $6.25M | +21.2% |
| 2014 | $5.16M | -9.1% |
| 2013 | $5.67M | -32.5% |
| 2012 | $8.41M | -34.8% |
| 2011 | $12.89M | +5.2% |
| 2010 | $12.24M | -14.1% |
| 2009 | $14.26M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.55M | +3.7% | +43.3% |
| June 30, 2025 | $1.78M | -21.8% | -24.4% |
| March 31, 2025 | $2.35M | +4.8% | -4.2% |
| September 30, 2024 | $2.45M | -8.0% | +8.0% |
| June 30, 2024 | $2.27M | -14.1% | +1.3% |
| March 31, 2024 | $2.24M | -18.3% | -15.9% |
| September 30, 2023 | $2.67M | -5.3% | +0.8% |
| June 30, 2023 | $2.65M | -8.5% | -3.6% |
- Stereotaxis, Inc. showed a decrease of -3.9% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, Stereotaxis, Inc.’s r&d expense has declined by 34.2% (from $14.26 million to $9.38 million).
- The most recent figure is from Stereotaxis, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: